MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Examining Device-Driven Therapies for Interventional Heart Failure
By Ulrich Jorde, MD, and Nils Johnson, MD
Diagnosing Gray Zone Coronary Physiology
Moderator: William F. Fearon, MDPanel: Morton J. Kern, MD, MSCAI, FAHA, FACC; Nils P. Johnson, MD, MS; and John McBarron Hodgson, MD, MSCAI
Findings Reported From DEFINE-FLOW Study of Deferral of PCI in FFR-Abnormal Lesions With Preserved Coronary Flow Reserve
October 16, 2020—A new observational study of deferred lesions following combined fractional flow reserve (FFR) and coronary flow reserve (CFR) assessments found that untreated vessels with abnormal FFR but intact CFR do not have noninferior outcomes compared to those with an FFR > 0.8 and a CFR ≥ 2.0 when treated medically.
Challenging Cases: What Would You Do?
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Shakeel A. Qureshi, MD, FRCP, FRCPCH
